Nanoparticles provoke immune response against tumors but avoid side effects
Researchers find that when immunostimulatory drugs called imidazoquinolines are delivered using specialized bottlebrush nanoparticles, the drugs provoke the immune system to attack tumors while eliminating the side effects that occur when the drugs are given on their own.
Materials provided by Massachusetts Institute of Technology. Original written by Anne Trafton. Note: Content may be edited for style and length.
Source link aaaaa